J Med Genet. 2017 May 10. pii: jmedgenet-2017-104584. doi: 10.1136/jmedgenet-2017-104584. [Epub ahead of print]
Pathology update to the Manchester Scoring System based on testing in over 4000 families.
Evans DG1,2,3,4,5, Harkness EF6, Plaskocinska I7, Wallace AJ3, Clancy T3, Woodward ER1,3, Howell TA2,5, Tischkowitz M7, Lalloo F3.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
BRCA1; BRCA2; Manchester Scoring System; high grade serous ovarian cancer; pathology; triple negative breast cancer